Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Clinical Infectious Diseases | 2008 | 2.1K |
Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases | Clinical Infectious Diseases | 1990 | 663 |
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America | Clinical Infectious Diseases | 2000 | 641 |
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial | Clinical Infectious Diseases | 2007 | 640 |
Paracoccidioidomycosis: an update | Clinical Microbiology Reviews | 1993 | 547 |
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials | Clinical Infectious Diseases | 2012 | 545 |
Coccidioidomycosis | Clinical Infectious Diseases | 2005 | 515 |
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference | Clinical Infectious Diseases | 2003 | 506 |
Pulmonary aspergillosis in the acquired immunodeficiency syndrome | New England Journal of Medicine | 1991 | 420 |
Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis | Chest | 2004 | 417 |
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis | American Journal of Medicine | 1994 | 412 |
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis | New England Journal of Medicine | 2000 | 400 |
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group | Aids | 1999 | 399 |
Itraconazole resistance in Aspergillus fumigatus | Antimicrobial Agents and Chemotherapy | 1997 | 397 |
Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey | Clinical Infectious Diseases | 2005 | 385 |
Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth | Cancer Cell | 2010 | 376 |
Resistance mechanisms in clinical isolates of Candida albicans | Antimicrobial Agents and Chemotherapy | 2002 | 369 |
Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women | Diabetes, Obesity and Metabolism | 2006 | 363 |
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis | Clinical Infectious Diseases | 2001 | 354 |
Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths | Annals of Internal Medicine | 2006 | 351 |
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care | Diabetes Care | 2008 | 349 |
Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician | Archives of Internal Medicine | 1999 | 345 |
Treatment of invasive aspergillosis with itraconazole | American Journal of Medicine | 1989 | 345 |
Coccidioidomycosis | New England Journal of Medicine | 1995 | 335 |
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease | World Journal of Gastroenterology | 2017 | 316 |